Clinical and Applied Thrombosis/Hemostasis

Clinical and Applied Thrombosis-Hemostasis journal front cover image

Clinical and Applied Thrombosis/Hemostasis is a peer-reviewed medical journal that focuses on the fields of thrombosis and hemostasis. The journal publishes original research articles, review articles, case reports, and brief communications related to the prevention, diagnosis, and management of thrombotic and bleeding disorders. The scope of the journal encompasses basic science, clinical trials, and patient-centered research, providing a comprehensive resource for healthcare professionals, researchers, and educators involved in the care of patients with or at risk for thrombotic and bleeding disorders.

Scope and Focus

The primary focus of Clinical and Applied Thrombosis/Hemostasis is on the clinical aspects of thrombosis and hemostasis, including the treatment and prevention of deep vein thrombosis (DVT), pulmonary embolism (PE), arterial thrombosis, stroke, and bleeding disorders. The journal also covers research on the underlying mechanisms of these conditions, advancements in diagnostic techniques, and the development of new therapeutic approaches. Topics such as anticoagulation therapy, platelet function, fibrinolysis, and the genetic factors influencing thrombosis and hemostasis are regularly featured.

Article Types

Clinical and Applied Thrombosis/Hemostasis publishes a variety of article types, including:

• Original Research Articles: Detailed reports of current research in the field of thrombosis and hemostasis.
• Review Articles: Comprehensive overviews of specific topics within the journal's scope, summarizing current knowledge and identifying future directions.
• Case Reports: Descriptions of particular clinical cases that provide insights into the diagnosis, management, or pathophysiology of thrombotic and bleeding disorders.
• Brief Communications: Short reports of original research or novel clinical observations.

Editorial Policies and Peer Review

The journal operates under a rigorous peer-review process to ensure the accuracy, relevance, and originality of the content it publishes. Manuscripts submitted to Clinical and Applied Thrombosis/Hemostasis undergo a double-blind peer review, where both the reviewers and the authors are anonymized to maintain impartiality and confidentiality. The journal's editorial board comprises experts in the fields of thrombosis and hemostasis, who oversee the review process and ensure the high scientific standards of the published articles.

Audience

The audience of Clinical and Applied Thrombosis/Hemostasis includes physicians, nurses, pharmacists, and other healthcare professionals involved in the care of patients with thrombotic and bleeding disorders. Researchers in the field of thrombosis and hemostasis, as well as medical educators and students, also constitute a significant portion of the journal's readership.

Access and Distribution

Clinical and Applied Thrombosis/Hemostasis is available in both print and online formats. The journal provides access to its articles through various subscription models and also offers options for open access publication, enabling authors to make their work freely available to the public and the scientific community.

‎